Description
Merva D3 (10.000 I.U)
-1st cholecalciferol in scored tablet (two concentrations in one tablet) in the Egyptian market.
-Provides therapeutic doses for all patients through suitable concentrations.
-Small-sized tablet easy to swallow.
-Coated tablet without a bad taste.
-Ensures patient compliance.
*MERVA- D3 supplementation is needed for the prevention of osteoporosis and for pain relief in patients with rheumatoid arthritis.
*MERVA- D3 replacement is a key therapeutic element in the management of hypoparathyroidism.
*Individuals with low blood levels of vitamin D have increased risks of heart disease, stroke, hypertension, and diabetes.
*A high prevalence of vitamin D insufficiency is demonstrated in overweight and obese children and adolescents.
*Obese people need higher loading doses of vitamin D to achieve the same serum 25-hydroxyvitamin D as normal weight.
*MERVA- D3 used in patients with COPD could improve lung function.
*MERVA- D3 can be effective as an adjunct therapy in the management of asthma.
There are no reviews yet.